Keyphrases
Indonesia
100%
Jakarta
42%
Dengue Virus
32%
Indonesian
29%
COVID-19
23%
Quantitative PCR
19%
Mycobacterium Tuberculosis (M. tb)
18%
Dengue Infection
17%
Dengue
15%
HIV Patients
15%
Intensive Care Unit
13%
Cytomegalovirus
12%
Pseudomonas Aeruginosa (P. aeruginosa)
11%
Dengue Virus Serotype 2
11%
Modul
11%
Antiretroviral Therapy
10%
Leaf Extract
9%
Virus
9%
Polymerase Chain Reaction
8%
Pandemi
8%
Antibiotics
8%
Klebsiella Pneumoniae (K. pneumoniae)
8%
Recombinant
7%
Carbapenem-susceptible
7%
Referral Hospital
7%
Tuberculosis
7%
Non-structural Protein
7%
Escherichia Coli
7%
Salmonella Typhi (S. Typhi)
7%
Sputum
7%
Measles Virus
7%
Genotype
7%
Pada
6%
Laboratorium
6%
Vaccine Candidate
6%
Antiviral Activity
6%
Typhoid Fever
6%
HPV16
6%
Diphtheria
6%
Depok
6%
Hospital Preparedness
6%
Webinar
6%
Acinetobacter Baumannii (A. baumannii)
6%
Dengue Fever
5%
Amino Acid Sequence
5%
Human Immunodeficiency Virus Type 1 (HIV-1)
5%
Staphylococcus Aureus
5%
PcDNA3.1
5%
Risk Factors
5%
AIDS/HIV
5%
Vaccine Virus
5%
DNA Vaccine
5%
Polymerase Chain Reaction Assay
5%
Pharmacology, Toxicology and Pharmaceutical Science
Dengue Virus
32%
Infection
31%
Disease
19%
Dengue
14%
Mycobacterium Tuberculosis
13%
Antivirus Agent
13%
Coronavirinae
12%
SARS Coronavirus
12%
Pseudomonas aeruginosa
12%
HIV
11%
Antibiotic Agent
10%
Mouse
10%
Symptom
10%
Antiinfective Agent
9%
Escherichia coli
9%
Amino Acid
8%
Antibiotics
8%
Microorganism
8%
Prevalence
8%
Midazolam
8%
Virus Infection
7%
Typhoid Fever
7%
Acinetobacter Baumannii
7%
Infectious Agent
6%
Nonstructural Protein 1
6%
Diphtheria
5%
Dengue Virus 2
5%
Measles Virus
5%
Cross-Sectional Study
5%
Salmonella Enterica Serovar Typhi
5%
Staphylococcus Aureus
5%
Measles Vaccine
5%
Severe Acute Respiratory Syndrome
5%
Placebo
5%
Immunology and Microbiology
Dengue Virus
27%
Human Immunodeficiency Virus
26%
Dengue Fever
26%
Serotype
17%
Mycobacterium Tuberculosis
12%
Vaccine Efficacy
12%
Escherichia coli
10%
Polymerase Chain Reaction
10%
Viral Disease
10%
Cytomegalovirus
9%
Mouse
8%
Sputum
8%
Pseudomonas aeruginosa
7%
Polymerase Chain Reaction
7%
Blood Plasma
7%
COVID-19
7%
Human Immunodeficiency Virus 1
7%
Infectious Agent
7%
Prevalence
6%
Wild Type
6%
Real Time Polymerase Chain Reaction
6%
Microorganism
6%
Monospecific Antibody
6%
Measles Vaccine
6%
Measles Virus
6%
DNA Vaccine
6%
Antibiotic Sensitivity
5%
Dengue Virus 2
5%
Acinetobacter Baumannii
5%
T Cell
5%
Tumor Necrosis Factor
5%
Amino Acid Sequence
5%
Antimicrobial Resistance
5%
Plasmid
5%